INAVA and breast cancer: Altogether, we identified a role for the uncharacterised protein C1orf106 in promoting breast cancer cell line tumourigenicity, and high expression was positively correlated with poor prognosis of breast cancer patients, supporting a role for C1orf106 as a tumour promoter in breast cancer.